BBL.BK · Capital · Negative Q3/2026 profit expected down 8.8% YoY due to high base of securities trading revenue, particularly at Bangkok Bank, though QoQ up 5% on lower OPEX and ECL.
KTB.BK · Capital · Positive Krungthai Bank leads QoQ growth at 7% on recovery in net interest income and trading revenue, and is Asia Plus's top strategic pick.
KKP.BK · Capital · Positive KKP is one of only three banks expected to post year-on-year profit increases in Q3/2026.
TISCO.BK · Capital · Positive TISCO is one of only three banks expected to post year-on-year profit increases in Q3/2026.
KBANK.BK · Capital · Neutral Named as Asia Plus's second top strategic pick after KTB, but no specific Q3 profit estimate given; other banks flat to down 1-2%.
TTB.BK · Capital · Positive TTB is among only three banks expected to post year-on-year profit increases in Q3/2026, per Asia Plus Securities.
TU.BK · Capital · Positive Asia Plus maintains Buy on TU with 13.90 baht target, forecasting 3Q26 net profit of 1.3bn baht, up 16% y/y on sales growth and high margins.
BH.BK · Demand · Positive BH benefits most, with Middle Eastern patients about 23% of revenue, as tourist numbers recover and complex high-margin cases return.
BDMS.BK · Demand · Positive BDMS is named as a standout beneficiary as returning Middle Eastern tourists (about 4% of revenue) drive higher-margin complex cases and stronger Q3 2026 profit.
PR9.BK · Demand · Positive PR9 is cited as a standout, with Middle Eastern patients about 10% of revenue, supported by recovering tourist arrivals and complex cases.
BEM.BK · Capital · Positive Named among the brokerage's recommended stocks benefiting from a new round of public and private investment with strong Q3 2026 growth momentum.
CHG.BK · Capital · Positive CHG is included in Yuanta's recommended list of stocks with strong Q3 2026 earnings growth momentum continuing into next year.
EPG.BK · Capital · Positive EPG is one of the brokerage's picks to trade for gains on strong Q3 2026 results and new investment-driven momentum.
GULF.BK · Capital · Positive GULF is named in Yuanta's recommended group benefiting from a new round of public and private investment.
GUNKUL.BK · Capital · Positive GUNKUL is included among the brokerage's recommended stocks with strong Q3 2026 profit growth momentum.
MINT.BK · Demand · Positive Named among recommended stocks benefiting from new public/private investment and returning tourism growth.
元大証券は、SINGER Thailand Public Company Limited(SINGER)に対する強気のアナリストリポートを発表した。同社がSINGERブランドの家電「S-PROシリーズ」を投入したことを受けたもので、初期はテレビ、業務用冷凍庫、エアコン、洗濯機に注力する。これらは新たなOEMが製造するため粗利益率が上昇し、プロダクトマージンを2026年上半期の31.4%から40%へ引き上げることを目標としている。スマートフォンと同様の機器ロック機能を搭載し、SGCのSG Finance+を通じた分割払い販売が可能で、家電ローン金利はロックフォンと同水準の年25%程度となる。同社はまた、JMARTが50%、GUNKULが40%、SINGERが10%を出資する合弁会社JGSを通じてソーラールーフ事業を拡大する計画で、ソーラールーフショップの開設やSGCを通じたローン提供、ソーラールーフを第一弾とする新サービスSG Subscribe+も開始する。店舗拡大では、2026年第2四半期の101店舗から今年146店舗の新規開設を目標とし、営業員も2026年第2四半期に443人を増員したのに続き1000人を追加する。元大は、SINGERの2026年第3四半期純利益が前年同期比および前四半期比でともに顕著に加速し、第4四半期も前年同期比および前四半期比で成長を続けると予想。これにより2026年通年の純利益は6億4700万バーツとなり前年比516%増、2027年も前年比21.5%増となる見通し。投資判断は「買い」を維持し、2027年の適正価値は1株13.70バーツで、現在値から25%の上昇余地があるとした。
SINGER.BK · Capital · Positive Yuanta maintains Buy with 13.70 baht target and forecasts 516% 2026 net profit growth on higher gross margins.
SINGER.BK · Demand · Positive New S-PRO Series appliances, 146 new branches, 1,000 added sales staff and Solar Roof/Subscribe+ expansion drive product demand.
SGC.BK · · Neutral Mentioned only as the lender (SG Finance+/SGC) enabling SINGER's installment sales; no own development.
DQ · Capital · Neutral Fair value cut ~18% with JPMorgan Overweight ($22 target) vs Goldman Sell ($10 target) after Q2 non-GAAP net loss on lower ASPs and higher SG&A.
DQ · Tariff · Negative US government preparing a polysilicon price floor and tariffs, with Daqo cited among companies expected to be affected.
688303.CG · Capital · Neutral Parent Daqo New Energy's fair value cut and split analyst ratings (JPMorgan Overweight vs Goldman Sell) after a Q2 net loss.
688303.CG · Tariff · Negative US polysilicon price floor and tariffs cited as affecting Daqo New Energy, the parent of Xinjiang Daqo.
ANET · Demand · Positive Arista raised 2026 revenue guidance to $12.60B, including at least $3.50B from AI-related business, on AI-driven cloud networking demand.
ANET · Capital · Positive Arista was added to the S&P 100 in September 2026, reflecting its growing weight in large-cap U.S. equity indices.
Artificial Intelligence › AI Data Center & Build-out Demand
NVDA · Supply · Negative NVIDIA's supply and capacity commitments ballooned to $279B from $119B, a schedule that hinges on customer spending keeping pace and may be cancelled or rescheduled.
OpenAI · Capital · Neutral NVIDIA disclosed August guarantees capped at $105B for an OpenAI-related SB Energy buildout, but the article gives no clear read-through for OpenAI itself.
Critical Materials & Supply Chain › Copper Capital
0RQ9.LSE · Capital · Positive Analysts raised Lundin Mining's fair value estimate to CA$42.54 and clustered price targets in the low-to-mid CA$40s, with several upward revisions.
Electrification & Mobility › China NEV Leaders ▲Supply
KGEN.BK · Capital · Positive Broker flags KGEN turnaround as raising its stake in the EV plant to 60% shifts to full consolidation, lifting revenue to 25 billion baht and turning earnings positive.
Omoda & Jaecoo Manufacturing (Thailand) · Capital · Positive KGEN is raising its stake in Omoda & Jaecoo Manufacturing (Thailand) from 43.7% to 60%, shifting to full consolidation of the EV plant's revenue and profit.
Jaecoo (Chery Jaecoo Automobile) · Demand · Positive JAECOO and OMODA EV bookings at the Big Motor Sale 2026 totaled 5,028 units with deliveries in September-October 2026, supporting revenue growth.
Artificial Intelligence › AI Applications & Copilots Competition
FDS · Capital · Neutral Analysts split on FactSet: several raised price targets and William Blair upgraded to Outperform, while Goldman, Barclays, BofA and Wells Fargo stayed cautious on moderating ASV growth and soft FY27 guidance.
MTN · Capital · Negative Fiscal 2026 net income fell to $147.5M from $280M on historic-low Rockies snowfall, and pass units are down ~12% heading into fiscal 2027.
Artificial Intelligence › AI Applications & Copilots ▲Demand
FDS · Capital · Negative Full-year adjusted operating margin slipped 1.8 points to 34.5% on heavy infrastructure and cybersecurity spending.
FDS · Demand · Positive FactSet reported its largest-ever quarterly contract value jump, with organic subscription value up 7% to $2.568B and every region growing faster than a year earlier.
JBL · Capital · Positive Jabil guided fiscal 2027 core EPS to $17.55 (~34% growth) after Q4 revenue rose 29% and core EPS rose 34% to $4.40.
JBL · Demand · Positive AI-related revenue is set to jump 54% to $22.1 billion in fiscal 2027, with six customers expected to top $1 billion each.
JBL · Supply · Negative Memory is being pulled toward AI and hyperscale buyers, squeezing other markets, and net inventory days of 64 remain above the 55-60 day target.
AZZ · Capital · Positive Analysts project 17.42% EPS growth ahead of the October 13 earnings release, with a forward P/E below the industry average and a $161.67 fair value implying 16% upside.
Vor Biopharmaは、中国で実施された第3相試験の事後解析を報告した。それによると、テリタセプトは全身型重症筋無力症の成人患者において、深く持続的な臨床的奏効をもたらし、48週間にわたり概ね良好な忍容性を示した。解析では、最小症状発現に到達した患者の大半がその状態を維持し、残りの追跡期間の多くをこの状態で過ごしたことが強調された。新たなデータは奏効の深さと持続性を裏付けるものの、主要な近接カタリストである2027年のUPSTREAMグローバル第3相試験のトップライン結果や、グローバルデータがこれまでの中国での経験と一致しない可能性があるという中心的リスクを実質的に変えるものではない。この結果は、Vorが2026年9月初旬にグローバルUPSTREAM第3相gMG試験の組み入れを完了したことと並ぶものである。Vor Biopharmaの見通しでは、2029年までに売上高1億1100万ドル、利益1910万ドルを計上し、現在の6億2780万ドルから6億870万ドルの減益となると示唆され、適正価値は39ドル、現在の株価に対して109%の上昇余地があると予測している。
Biotech & Genomic Medicine › Autoimmune & Immunology Therapeutics Technology
VOR · Technology · Positive Post hoc Phase 3 analysis shows telitacicept produced deep, durable responses over 48 weeks in generalized myasthenia gravis, reinforcing the drug's clinical profile.
8344.JP · Demand · Neutral Alliance could lift fee income and customer stickiness, but account transfer and intermediary-model execution risks plus low ROE make the net impact unclear
8601.JP · Demand · Positive Daiwa will take over most local securities accounts and second specialists into Yamagata Bank, expanding its customer base and intermediary services
MU · Capital · Positive Micron beat sales and profit forecasts with blowout earnings and strong guidance driven by AI demand.
MU · Pricing · Positive Executives signaled tight capacity and higher prices for its products until 2028, extending strong pricing and earnings growth.
Artificial Intelligence › Agentic AI & Autonomous Workflows ▲Competition
Artificial Intelligence › AI Applications & Copilots Competition
BKNG · Competition · Negative Bernstein flags Booking as especially exposed to AI-agent risks of disintermediation and commission-rate pressure, with high-commission inventory providing an estimated 10% revenue uplift.
ABNB · Competition · Positive Bernstein says Airbnb is better positioned than Booking and Expedia against AI-agent disintermediation, citing exclusive listings and direct traffic.
EXPE · Competition · Negative Bernstein says Expedia faces greater long-term risk than Airbnb from AI agents, including disintermediation and price competition, and its brands rarely offered the cheapest US hotel rate.
Artificial Intelligence › Build-out, Construction & Engineering ▲Demand
Energy Transition & Power Demand › Grid, Transmission & Power Equipment ▲Demand
EFXT · Capital · Positive CIBC lifted its Enerflex price target to CA$30 after modeling the 450 MW data center power award and citing strong bookings and an EBITDA beat.
Artificial Intelligence › AI Applications & Copilots Capital
CRM · Capital · Positive Salesforce authorized a $50 billion buyback and executed half within weeks via the largest accelerated share repurchase in corporate history.
KKP.BK · Capital · Positive Pie Securities maintains Buy and raises KKP's fair value to 130 baht, forecasting 35% profit growth in 2026 and high dividend yield.
Artificial Intelligence › AI Compute & Accelerator Silicon Competition
ARM · Capital · Positive Arm reported fiscal Q1 revenue of $1.29B with royalties up 22% and licensing up 23%, plus a $1B capacity-secured revenue opportunity.
ARM · Competition · Neutral Arm's move to sell its own data-center CPU could capture more revenue per system but risks eroding its licensing neutrality with customers who compete for the same server budget.
VOD.LSE · Capital · Positive Analysts raised Vodafone's fair value to £1.22 and multiple banks lifted price targets/Buy ratings after stronger Q1 trading and the Vodafone Three stake acquisition.
IOVA · Capital · Positive Multiple analysts raised price targets and fair value on stronger Amtagvi launch expectations, margin trends, and revenue guidance.
IOVA · Demand · Positive FY26 revenue guidance tied to U.S. demand for Amtagvi and Proleukin, with an inflection in the Amtagvi launch.
C · · Neutral Citi's own research warns midterm political risk could weigh on equities before a year-end rally, but the note is a market call, not a company-specific development.